Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Neuralstem Inc.
ClinicalTrials.gov Identifier:
NCT01348451
First received: April 28, 2011
Last updated: March 9, 2016
Last verified: March 2016